---
title: CDMO Daily News — November 2, 2026
slug: daily-news-2026-11-02-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: November 2 CDMO daily: Lonza Enhances Bioconjugation Manufacturing Capacity in Visp with New Facilities; Cambrex Breaks Ground on $120M Charles City Expansion…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-11-02-cdmo
published_at: 2026-11-02T00:00:24.496Z
last_updated: 2026-11-02T00:01:20.711Z
---

### [Lonza](/companies/lonza) Enhances Bioconjugation Manufacturing Capacity in Visp with New Facilities
- [Lonza](/companies/lonza) is expanding its bioconjugation manufacturing capabilities in Visp, Switzerland, with three new multiproduct suites and upgraded mid-scale capacity.
- The mid-scale upgrade will provide 500-liter single-use capacity and is expected to be completed by 2027, while the new large-scale facility will be operational in 2028.

**Operational Impact**

The expansion will enhance [Lonza](/companies/lonza)'s ability to support multiple ADC programs and provide a scalable route to commercial production.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/lonza-expands-bioconjugation-manufacturing-capacity-in-visp-with-three-new-suites)*

---

### [Cambrex](/companies/cambrex) Breaks Ground on $120M Charles City Expansion Adding 160,000 Liters
- [Cambrex](/companies/cambrex) broke ground on a $120 million expansion at its Charles City, Iowa facility.
- The project adds 160,000 liters, raising total site capacity about 25% to nearly one million liters.
- The expansion targets small molecule API and synthetic peptide manufacturing, with completion expected in 4Q28.

**Operational Impact**

[Cambrex](/companies/cambrex)'s Charles City expansion adds 160,000 liters of U.S. small molecule and peptide capacity, which gives outsourcing teams a domestic option for programs moving toward commercial supply, though the capacity arrives only in 4Q28.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/cambrex-breaks-ground-on-120m-expansion-at-charles-city-site)*

---

### [Codis](/companies/codis) Begins Construction on PSD-4 Spray Drying Expansion at Haverhill, U.K.
- [Codis](/companies/codis) has completed demolition at its Haverhill, U.K. site and started construction on the PSD-4 expansion.
- The project will install a GEA Pharma-SD type PSD-4 solvent-capable spray dryer for commercial-scale amorphous solid dispersion manufacturing.
- Dryer Factory Acceptance Test is planned for November 2026, with new capacity expected in Q4 2027.

**Operational Impact**

[Codis](/companies/codis)'s Haverhill PSD-4 spray dryer adds commercial ASD capacity in the U.K. from Q4 2027, which matters for sponsors planning poorly soluble drug scale-up in that window.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/codis-begins-construction-on-psd-4-expansion-to-increase-spray-drying-capacity)*

## References

1. [PharmaSource RSS — Lonza Enhances Bioconjugation Manufacturing Capacity in Visp with New Facilities](https://pharmasource.global/content/news/cdmo-news/lonza-expands-bioconjugation-manufacturing-capacity-in-visp-with-three-new-suites)
2. [Contract Pharma Breaking News RSS — Cambrex Breaks Ground on $120M Charles City Expansion Adding 160,000 Liters](https://www.contractpharma.com/breaking-news/cambrex-breaks-ground-on-120m-expansion-at-charles-city-site)
3. [PharmaSource RSS — Codis Begins Construction on PSD-4 Spray Drying Expansion at Haverhill, U.K.](https://pharmasource.global/content/news/cdmo-news/codis-begins-construction-on-psd-4-expansion-to-increase-spray-drying-capacity)

Source: https://www.cdmo.directory/posts/daily-news-2026-11-02-cdmo